Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
US11186566B2 · kind B2 · utility
10Cited by
17References
10Claims
0Family size
Assignee
Inventors
- Timothy Alcacio
- Minson Baek
- Peter Diederik Jan Grootenhuis
- Sara S. Hadida Ruah
- Robert Michael Hughes
- Ali Keshavarz-Shokri
- Rachel McAuley-Aoki
- Jason McCartney
- Mark Miller
- Fredrick Van Goor
- Beili Zhang
- Corey Anderson
- Thomas Cleveland
- Bryan A. Frieman
- Haripada Khatuya
- Pramod Joshi
- Paul Krenitsky
- Vito Melillo
- Fabrice Pierre
- Andreas P. Termin
- Johnny Uy
- Jinglan Zhou
- Alexander Russell Abela
- Brett B. Busch
- Prasuna Paraselli
Key dates
| Filing date | Dec 4, 2019 |
| Grant date | Nov 30, 2021 |
| Priority date | — |
| Expiry date | Mar 19, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula I: pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.